title: A rare cause of gastric malignancy: Burkitt's lymphoma.
authors: Department of Gastroenterology, Huntsman Cancer Institute and University of Utah, Salt Lake City, Utah, USA.
authors: Iliana
authors: I
authors: Doycheva
authors: Department of Internal Medicine, Huntsman Cancer Institute and University of Utah, Salt Lake City, Utah, USA.
authors: Stacy
authors: S
authors: Tanner
authors: Department of Pathology, Huntsman Cancer Institute and University of Utah, Salt Lake City, Utah, USA.
authors: Delu
authors: D
authors: Zhou
authors: Department of Gastroenterology, Huntsman Cancer Institute and University of Utah, Salt Lake City, Utah, USA.
authors: N Jewel
authors: NJ
authors: Samadder
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D016099:Endoscopy, Gastrointestinal; D019160:Endosonography; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D013274:Stomach Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone